OTSU Stock Overview
Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Otsuka Pakistan Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | PK₨192.32 |
52 Week High | PK₨205.03 |
52 Week Low | PK₨105.05 |
Beta | 0.27 |
1 Month Change | 33.90% |
3 Month Change | 38.22% |
1 Year Change | 32.22% |
3 Year Change | -21.61% |
5 Year Change | -44.00% |
Change since IPO | 1,049.17% |
Recent News & Updates
Recent updates
Shareholder Returns
OTSU | PK Pharmaceuticals | PK Market | |
---|---|---|---|
7D | -3.6% | -5.4% | -4.6% |
1Y | 32.2% | 160.1% | 54.3% |
Return vs Industry: OTSU underperformed the PK Pharmaceuticals industry which returned 160.1% over the past year.
Return vs Market: OTSU underperformed the PK Market which returned 54.3% over the past year.
Price Volatility
OTSU volatility | |
---|---|
OTSU Average Weekly Movement | 10.3% |
Pharmaceuticals Industry Average Movement | 7.1% |
Market Average Movement | 7.1% |
10% most volatile stocks in PK Market | 10.1% |
10% least volatile stocks in PK Market | 4.8% |
Stable Share Price: OTSU's share price has been volatile over the past 3 months compared to the PK market.
Volatility Over Time: OTSU's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of PK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | 345 | Moin-ur Rehman | www.otsuka.pk |
Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. The company offers intravenous solutions, including electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products comprising aminoleban oral, aminovel 600, pan-amin G, aminoleban injection, and proten gold; and therapeutic drugs, which include pletaal and mucosta tablets, as well as oral rehydration therapy supplement for urinary tract. It engages in the trading of pharmaceutical products, nutritional foods, and medical equipment.
Otsuka Pakistan Limited Fundamentals Summary
OTSU fundamental statistics | |
---|---|
Market cap | PK₨2.33b |
Earnings (TTM) | -PK₨160.37m |
Revenue (TTM) | PK₨3.18b |
0.7x
P/S Ratio-14.5x
P/E RatioIs OTSU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OTSU income statement (TTM) | |
---|---|
Revenue | PK₨3.18b |
Cost of Revenue | PK₨2.68b |
Gross Profit | PK₨500.48m |
Other Expenses | PK₨660.85m |
Earnings | -PK₨160.37m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -13.25 |
Gross Margin | 15.74% |
Net Profit Margin | -5.04% |
Debt/Equity Ratio | 192.9% |
How did OTSU perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 04:20 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Otsuka Pakistan Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|